<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34678970</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2072-6651</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Sep</Month>
              <Day>23</Day>
            </PubDate>
          </JournalIssue>
          <Title>Toxins</Title>
          <ISOAbbreviation>Toxins (Basel)</ISOAbbreviation>
        </Journal>
        <ArticleTitle><i>Staphylococcus aureus</i> Toxins: An Update on Their Pathogenic Properties and Potential Treatments.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">677</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/toxins13100677</ELocationID>
        <Abstract>
          <AbstractText><i>Staphylococcus aureus</i> is a clinically important pathogen that causes a wide range of human infections, from minor skin infections to severe tissue infection and sepsis. <i>S. aureus</i> has a high level of antibiotic resistance and is a common cause of infections in hospitals and the community. The rising prevalence of community-acquired methicillin-resistant <i>S. aureus</i> (CA-MRSA), combined with the important severity of <i>S. aureus</i> infections in general, has resulted in the frequent use of anti-staphylococcal antibiotics, leading to increasing resistance rates. Antibiotic-resistant <i>S. aureus</i> continues to be a major health concern, necessitating the development of novel therapeutic strategies. <i>S. aureus</i> uses a wide range of virulence factors, such as toxins, to develop an infection in the host. Recently, anti-virulence treatments that directly or indirectly neutralize <i>S. aureus</i> toxins have showed promise. In this review, we provide an update on toxin pathogenic characteristics, as well as anti-toxin therapeutical strategies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ahmad-Mansour</LastName>
            <ForeName>Nour</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory of Pathogen Host Interactions, CNRS UMR5235, Université de Montpellier, 34000 Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loubet</LastName>
            <ForeName>Paul</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-1218-9432</Identifier>
            <AffiliationInfo>
              <Affiliation>Virulence Bactérienne et Infections Chroniques, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, 30908 Nîmes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pouget</LastName>
            <ForeName>Cassandra</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Virulence Bactérienne et Infections Chroniques, INSERM U1047, Université de Montpellier, 30908 Nîmes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dunyach-Remy</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0001-6884-470X</Identifier>
            <AffiliationInfo>
              <Affiliation>Virulence Bactérienne et Infections Chroniques, INSERM U1047, Department of Microbiology and Hospital Hygiene, Université de Montpellier, 30908 Nîmes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sotto</LastName>
            <ForeName>Albert</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-6463-9386</Identifier>
            <AffiliationInfo>
              <Affiliation>Virulence Bactérienne et Infections Chroniques, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, 30908 Nîmes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lavigne</LastName>
            <ForeName>Jean-Philippe</ForeName>
            <Initials>JP</Initials>
            <Identifier Source="ORCID">0000-0002-9484-0304</Identifier>
            <AffiliationInfo>
              <Affiliation>Virulence Bactérienne et Infections Chroniques, INSERM U1047, Department of Microbiology and Hospital Hygiene, Université de Montpellier, 30908 Nîmes, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Molle</LastName>
            <ForeName>Virginie</ForeName>
            <Initials>V</Initials>
            <Identifier Source="ORCID">0000-0002-6573-3411</Identifier>
            <AffiliationInfo>
              <Affiliation>Laboratory of Pathogen Host Interactions, CNRS UMR5235, Université de Montpellier, 34000 Montpellier, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>09</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Toxins (Basel)</MedlineTA>
        <NlmUniqueID>101530765</NlmUniqueID>
        <ISSNLinking>2072-6651</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014118">Toxins, Biological</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014118" MajorTopicYN="N">Toxins, Biological</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Staphylococcus aureus</Keyword>
        <Keyword MajorTopicYN="Y">anti-toxin strategies</Keyword>
        <Keyword MajorTopicYN="Y">pathogenicity</Keyword>
        <Keyword MajorTopicYN="Y">toxins</Keyword>
        <Keyword MajorTopicYN="Y">virulence</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>22</Day>
          <Hour>21</Hour>
          <Minute>3</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34678970</ArticleId>
        <ArticleId IdType="pmc">PMC8540901</ArticleId>
        <ArticleId IdType="doi">10.3390/toxins13100677</ArticleId>
        <ArticleId IdType="pii">toxins13100677</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., Nouwen J.L. The Role of Nasal Carriage in Staphylococcus aureus. Lancet Infect. Dis. 2005;5:751–762. doi: 10.1016/S1473-3099(05)70295-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(05)70295-4</ArticleId>
            <ArticleId IdType="pubmed">16310147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanselman B.A., Kruth S.A., Rousseau J., Weese J.S. Coagulase Positive Staphylococcal Colonization of Humans and Their Household Pets. Can. Vet. J. 2009;50:954–958.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2726022</ArticleId>
            <ArticleId IdType="pubmed">19949556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tong S.Y.C., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clin. Microbiol. Rev. 2015;28:603–661. doi: 10.1128/CMR.00134-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00134-14</ArticleId>
            <ArticleId IdType="pmc">PMC4451395</ArticleId>
            <ArticleId IdType="pubmed">26016486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antimicrobial Resistance in the EU/EEA (EARS-Net)—Annual Epidemiological Report for 2019.  [(accessed on 23 August 2021)].  Available online:  https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Borg M.A., Camilleri L. What Is Driving the Epidemiology of Methicillin-Resistant Staphylococcus aureus Infections in Europe? Microb. Drug Resist. 2020;27:889–894. doi: 10.1089/mdr.2020.0259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2020.0259</ArticleId>
            <ArticleId IdType="pubmed">33337277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowy F.D. Staphylococcus aureus Infections. N. Engl. J. Med. 1998;339:520–532. doi: 10.1056/NEJM199808203390806.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199808203390806</ArticleId>
            <ArticleId IdType="pubmed">9709046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tam K., Torres V.J. Staphylococcus aureus Secreted Toxins and Extracellular Enzymes. Microbiol. Spectr. 2019;7:16. doi: 10.1128/microbiolspec.GPP3-0039-2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/microbiolspec.GPP3-0039-2018</ArticleId>
            <ArticleId IdType="pmc">PMC6422052</ArticleId>
            <ArticleId IdType="pubmed">30873936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira D., Borges A., Simões M. Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases. Toxins. 2018;10:252.  doi: 10.3390/toxins10060252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins10060252</ArticleId>
            <ArticleId IdType="pmc">PMC6024779</ArticleId>
            <ArticleId IdType="pubmed">29921792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimaoka M., Yoh M., Takarada Y., Yamamoto K., Honda T. Detection of the Gene for Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus by Enzyme-Labelled Oligonucleotide Probes. J. Med. Microbiol. 1996;44:215–218. doi: 10.1099/00222615-44-3-215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/00222615-44-3-215</ArticleId>
            <ArticleId IdType="pubmed">8636940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu M., Liu J., Guo Y., Zhang Z. Characterization of Virulence Factors and Genetic Background of Staphylococcus aureus Isolated from Peking University People’s Hospital between 2005 and 2009. Curr. Microbiol. 2010;61:435–443. doi: 10.1007/s00284-010-9635-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00284-010-9635-0</ArticleId>
            <ArticleId IdType="pubmed">20383506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ezeamagu C., Imanatue I., Dosunmu M., Odeseye A., Baysah G., Aina D., Odutayo F., Mensah-Agyei G. Detection of Methicillin Resistant and Toxin-Associated Genes in Staphylococcus aureus. Beni-Suef Univ. J. Basic Appl. Sci. 2018;7:92–97. doi: 10.1016/j.bjbas.2017.07.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjbas.2017.07.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suaya J.A., Mera R.M., Cassidy A., O’Hara P., Amrine-Madsen H., Burstin S., Miller L.G. Incidence and Cost of Hospitalizations Associated with Staphylococcus aureus Skin and Soft Tissue Infections in the United States from 2001 through 2009. BMC Infect. Dis. 2014;14:296.  doi: 10.1186/1471-2334-14-296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-14-296</ArticleId>
            <ArticleId IdType="pmc">PMC4060579</ArticleId>
            <ArticleId IdType="pubmed">24889406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhen X., Lundborg C.S., Zhang M., Sun X., Li Y., Hu X., Gu S., Gu Y., Wei J., Dong H. Clinical and Economic Impact of Methicillin-Resistant Staphylococcus aureus: A Multicentre Study in China. Sci. Rep. 2020;10:3900. doi: 10.1038/s41598-020-60825-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-60825-6</ArticleId>
            <ArticleId IdType="pmc">PMC7054446</ArticleId>
            <ArticleId IdType="pubmed">32127606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egorov A.M., Ulyashova M.M., Rubtsova M.Y. Bacterial Enzymes and Antibiotic Resistance. Acta Naturae. 2018;10:33–48. doi: 10.32607/20758251-2018-10-4-33-48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.32607/20758251-2018-10-4-33-48</ArticleId>
            <ArticleId IdType="pmc">PMC6351036</ArticleId>
            <ArticleId IdType="pubmed">30713760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varela M.F., Stephen J., Lekshmi M., Ojha M., Wenzel N., Sanford L.M., Hernandez A.J., Parvathi A., Kumar S.H. Bacterial Resistance to Antimicrobial Agents. Antibiotics. 2021;10:593.  doi: 10.3390/antibiotics10050593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/antibiotics10050593</ArticleId>
            <ArticleId IdType="pmc">PMC8157006</ArticleId>
            <ArticleId IdType="pubmed">34067579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tackling Drug-Resistant Infections Globally: Final Report and Recommendations—The Review on Antimicrobial Resistance.  [(accessed on 23 August 2021)].  Available online:  https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf.</Citation>
        </Reference>
        <Reference>
          <Citation>Fleitas Martínez O., Cardoso M.H., Ribeiro S.M., Franco O.L. Recent Advances in Anti-Virulence Therapeutic Strategies with a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition. Front. Cell. Infect. Microbiol. 2019;9:74. doi: 10.3389/fcimb.2019.00074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2019.00074</ArticleId>
            <ArticleId IdType="pmc">PMC6454102</ArticleId>
            <ArticleId IdType="pubmed">31001485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim M.-K. Staphylococcus aureus Toxins: From Their Pathogenic Roles to Anti-Virulence Therapy Using Natural Products. Biotechnol. Bioprocess Eng. 2019;24:424–435. doi: 10.1007/s12257-019-0059-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12257-019-0059-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett M.R., Thomsen I.P. Epidemiological and Clinical Evidence for the Role of Toxins in Staphylococcus aureus Human Disease. Toxins. 2020;12:408.  doi: 10.3390/toxins12060408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins12060408</ArticleId>
            <ArticleId IdType="pmc">PMC7354447</ArticleId>
            <ArticleId IdType="pubmed">32575633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vlaeminck J., Raafat D., Surmann K., Timbermont L., Normann N., Sellman B., van Wamel W.J.B., Malhotra-Kumar S. Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia. Toxins. 2020;12:721.  doi: 10.3390/toxins12110721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins12110721</ArticleId>
            <ArticleId IdType="pmc">PMC7698915</ArticleId>
            <ArticleId IdType="pubmed">33218049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ford C.A., Hurford I.M., Cassat J.E. Antivirulence Strategies for the Treatment of Staphylococcus aureus Infections: A Mini Review. Front. Microbiol. 2021;11:3568. doi: 10.3389/fmicb.2020.632706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2020.632706</ArticleId>
            <ArticleId IdType="pmc">PMC7840885</ArticleId>
            <ArticleId IdType="pubmed">33519793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Divyakolu S., Chikkala R., Ratnakar K.S., Sritharan V. Hemolysins of Staphylococcus aureus—An Update on Their Biology, Role in Pathogenesis and as Targets for Anti-Virulence Therapy. Adv. Infect. Dis. 2019;9:80–104. doi: 10.4236/aid.2019.92007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4236/aid.2019.92007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berube B.J., Wardenburg J.B. Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue. Toxins. 2013;5:1140–1166. doi: 10.3390/toxins5061140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins5061140</ArticleId>
            <ArticleId IdType="pmc">PMC3717774</ArticleId>
            <ArticleId IdType="pubmed">23888516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernandez S.L., Nelson M., Sampedro G.R., Bagrodia N., Defnet A.M., Lec B., Emolo J., Kirschner R., Wu L., Biermann H., et al.  Staphylococcus aureus Alpha Toxin Activates Notch in Vascular Cells. Angiogenesis. 2019;22:197–209. doi: 10.1007/s10456-018-9650-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10456-018-9650-5</ArticleId>
            <ArticleId IdType="pmc">PMC6360126</ArticleId>
            <ArticleId IdType="pubmed">30324336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhakdi S., Tranum-Jensen J. Alpha-Toxin of Staphylococcus aureus. Microbiol. Rev. 1991;55:733–751. doi: 10.1128/mr.55.4.733-751.1991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mr.55.4.733-751.1991</ArticleId>
            <ArticleId IdType="pmc">PMC372845</ArticleId>
            <ArticleId IdType="pubmed">1779933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereira-Franchi E.P.L., Barreira M.R.N., de Costa N.d.S.L.M., Riboli D.F.M., Abraão L.M., Martins K.B., Victória C., da Cunha M.d.L.R.d.S. Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in the Brazilian Primary Health Care System. Trop. Med. Int. Health. 2019;24:339–347. doi: 10.1111/tmi.13192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/tmi.13192</ArticleId>
            <ArticleId IdType="pubmed">30549385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bubeck Wardenburg J., Palazzolo-Ballance A.M., Otto M., Schneewind O., DeLeo F.R. Panton-Valentine Leukocidin Is Not a Virulence Determinant in Murine Models of Community-Associated Methicillin-Resistant Staphylococcus aureus Disease. J. Infect. Dis. 2008;198:1166–1170. doi: 10.1086/592053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/592053</ArticleId>
            <ArticleId IdType="pmc">PMC2574921</ArticleId>
            <ArticleId IdType="pubmed">18729780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crémieux A.-C., Saleh-Mghir A., Danel C., Couzon F., Dumitrescu O., Lilin T., Perronne C., Etienne J., Lina G., Vandenesch F. α-Hemolysin, Not Panton-Valentine Leukocidin, Impacts Rabbit Mortality from Severe Sepsis with Methicillin-Resistant Staphylococcus aureus Osteomyelitis. J. Infect. Dis. 2014;209:1773–1780. doi: 10.1093/infdis/jit840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jit840</ArticleId>
            <ArticleId IdType="pubmed">24376272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montgomery C.P., Boyle-Vavra S., Adem P.V., Lee J.C., Husain A.N., Clasen J., Daum R.S. Comparison of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus Pulsotypes USA300 and USA400 in a Rat Model of Pneumonia. J. Infect. Dis. 2008;198:561–570. doi: 10.1086/590157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/590157</ArticleId>
            <ArticleId IdType="pubmed">18598194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spaan A.N., van Strijp J.A.G., Torres V.J. Leukocidins: Staphylococcal Bi-Component Pore-Forming Toxins Find Their Receptors. Nat. Rev. Microbiol. 2017;15:435–447. doi: 10.1038/nrmicro.2017.27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro.2017.27</ArticleId>
            <ArticleId IdType="pmc">PMC5621924</ArticleId>
            <ArticleId IdType="pubmed">28420883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grumann D., Nübel U., Bröker B.M. Staphylococcus aureus Toxins–Their Functions and Genetics. Infect. Genet. Evol. 2014;21:583–592. doi: 10.1016/j.meegid.2013.03.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.meegid.2013.03.013</ArticleId>
            <ArticleId IdType="pubmed">23541411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alonzo F., Kozhaya L., Rawlings S.A., Reyes-Robles T., DuMont A.L., Myszka D.G., Landau N.R., Unutmaz D., Torres V.J. CCR5 Is a Receptor for Staphylococcus aureus Leukotoxin ED. Nature. 2013;493:51–55. doi: 10.1038/nature11724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11724</ArticleId>
            <ArticleId IdType="pmc">PMC3536884</ArticleId>
            <ArticleId IdType="pubmed">23235831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spaan A.N., Henry T., van Rooijen W.J.M., Perret M., Badiou C., Aerts P.C., Kemmink J., de Haas C.J.C., van Kessel K.P.M., Vandenesch F., et al.  The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors. Cell Host Microbe. 2013;13:584–594. doi: 10.1016/j.chom.2013.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2013.04.006</ArticleId>
            <ArticleId IdType="pubmed">23684309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DuMont A.L., Yoong P., Day C.J., Alonzo F., McDonald W.H., Jennings M.P., Torres V.J. Staphylococcus aureus LukAB Cytotoxin Kills Human Neutrophils by Targeting the CD11b Subunit of the Integrin Mac-1. Proc. Natl. Acad. Sci. USA. 2013;110:10794–10799. doi: 10.1073/pnas.1305121110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1305121110</ArticleId>
            <ArticleId IdType="pmc">PMC3696772</ArticleId>
            <ArticleId IdType="pubmed">23754403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaneko J., Kamio Y. Bacterial Two-Component and Hetero-Heptameric Pore-Forming Cytolytic Toxins: Structures, Pore-Forming Mechanism, and Organization of the Genes. Biosci. Biotechnol. Biochem. 2004;68:981–1003. doi: 10.1271/bbb.68.981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1271/bbb.68.981</ArticleId>
            <ArticleId IdType="pubmed">15170101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shallcross L.J., Fragaszy E., Johnson A.M., Hayward A.C. The Role of the Panton-Valentine Leucocidin Toxin in Staphylococcal Disease: A Systematic Review and Meta-Analysis. Lancet Infect. Dis. 2013;13:43–54. doi: 10.1016/S1473-3099(12)70238-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(12)70238-4</ArticleId>
            <ArticleId IdType="pmc">PMC3530297</ArticleId>
            <ArticleId IdType="pubmed">23103172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otter J.A., French G.L. Molecular Epidemiology of Community-Associated Meticillin-Resistant Staphylococcus aureus in Europe. Lancet Infect. Dis. 2010;10:227–239. doi: 10.1016/S1473-3099(10)70053-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(10)70053-0</ArticleId>
            <ArticleId IdType="pubmed">20334846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mesrati I., Saïdani M., Ennigrou S., Zouari B., Ben Redjeb S. Clinical Isolates of Pantone-Valentine Leucocidin- and Gamma-Haemolysin-Producing Staphylococcus aureus: Prevalence and Association with Clinical Infections. J. Hosp. Infect. 2010;75:265–268. doi: 10.1016/j.jhin.2010.03.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhin.2010.03.015</ArticleId>
            <ArticleId IdType="pubmed">20635511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otto M. Phenol-Soluble Modulins. Int. J. Med. Microbiol. 2014;304:164–169. doi: 10.1016/j.ijmm.2013.11.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2013.11.019</ArticleId>
            <ArticleId IdType="pmc">PMC4014003</ArticleId>
            <ArticleId IdType="pubmed">24447915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peschel A., Otto M. Phenol-Soluble Modulins and Staphylococcal Infection. Nat. Rev. Microbiol. 2013;11:667–673. doi: 10.1038/nrmicro3110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro3110</ArticleId>
            <ArticleId IdType="pmc">PMC4780437</ArticleId>
            <ArticleId IdType="pubmed">24018382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheung G.Y.C., Joo H.-S., Chatterjee S.S., Otto M. Phenol-Soluble Modulins–Critical Determinants of Staphylococcal Virulence. FEMS Microbiol. Rev. 2014;38:698–719. doi: 10.1111/1574-6976.12057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1574-6976.12057</ArticleId>
            <ArticleId IdType="pmc">PMC4072763</ArticleId>
            <ArticleId IdType="pubmed">24372362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baldry M., Bojer M.S., Najarzadeh Z., Vestergaard M., Meyer R.L., Otzen D.E., Ingmer H. Phenol-Soluble Modulins Modulate Persister Cell Formation in Staphylococcus aureus. Front. Microbiol. 2020;11:573253. doi: 10.3389/fmicb.2020.573253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2020.573253</ArticleId>
            <ArticleId IdType="pmc">PMC7680730</ArticleId>
            <ArticleId IdType="pubmed">33240231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaman M., Andreasen M. Cross-Talk between Individual Phenol-Soluble Modulins in Staphylococcus aureus Biofilm Enables Rapid and Efficient Amyloid Formation. eLife. 2020;9:e59776. doi: 10.7554/eLife.59776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.59776</ArticleId>
            <ArticleId IdType="pmc">PMC7732344</ArticleId>
            <ArticleId IdType="pubmed">33259287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Queck S.Y., Jameson-Lee M., Villaruz A.E., Bach T.-H.L., Khan B.A., Sturdevant D.E., Ricklefs S.M., Li M., Otto M. RNAIII-Independent Target Gene Control by the Agr Quorum-Sensing System: Insight into the Evolution of Virulence Regulation in Staphylococcus aureus. Mol. Cell. 2008;32:150–158. doi: 10.1016/j.molcel.2008.08.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2008.08.005</ArticleId>
            <ArticleId IdType="pmc">PMC2575650</ArticleId>
            <ArticleId IdType="pubmed">18851841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zapf R.L., Wiemels R.E., Keogh R.A., Holzschu D.L., Howell K.M., Trzeciak E., Caillet A.R., King K.A., Selhorst S.A., Naldrett M.J., et al.  The Small RNA Teg41 Regulates Expression of the Alpha Phenol-Soluble Modulins and Is Required for Virulence in Staphylococcus aureus. MBio. 2019;10:e02484-18. doi: 10.1128/mBio.02484-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.02484-18</ArticleId>
            <ArticleId IdType="pmc">PMC6428751</ArticleId>
            <ArticleId IdType="pubmed">30723124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kretschmer D., Gleske A.-K., Rautenberg M., Wang R., Köberle M., Bohn E., Schöneberg T., Rabiet M.-J., Boulay F., Klebanoff S.J., et al.  Human Formyl Peptide Receptor 2 Senses Highly Pathogenic Staphylococcus aureus. Cell Host Microbe. 2010;7:463–473. doi: 10.1016/j.chom.2010.05.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2010.05.012</ArticleId>
            <ArticleId IdType="pmc">PMC3417054</ArticleId>
            <ArticleId IdType="pubmed">20542250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schreiner J., Kretschmer D., Klenk J., Otto M., Bühring H.-J., Stevanovic S., Wang J.M., Beer-Hammer S., Peschel A., Autenrieth S.E. Staphylococcus aureus Phenol-Soluble Modulin Peptides Modulate Dendritic Cell Functions and Increase In Vitro Priming of Regulatory T Cells. J. Immunol. 2013;190:3417–3426. doi: 10.4049/jimmunol.1202563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1202563</ArticleId>
            <ArticleId IdType="pmc">PMC3608756</ArticleId>
            <ArticleId IdType="pubmed">23460735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R., Braughton K.R., Kretschmer D., Bach T.-H.L., Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., et al.  Identification of Novel Cytolytic Peptides as Key Virulence Determinants for Community-Associated MRSA. Nat. Med. 2007;13:1510–1514. doi: 10.1038/nm1656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1656</ArticleId>
            <ArticleId IdType="pubmed">17994102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez D.J., Vuong L., Gonzalez I.S., Keller N., McGrosso D., Hwang J.H., Hung J., Zinkernagel A., Dixon J.E., Dorrestein P.C., et al.  Phenol Soluble Modulin (PSM) Variants of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Captured Using Mass Spectrometry-Based Molecular Networking. Mol. Cell. Proteom. 2014;13:1262–1272. doi: 10.1074/mcp.M113.031336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/mcp.M113.031336</ArticleId>
            <ArticleId IdType="pmc">PMC4014283</ArticleId>
            <ArticleId IdType="pubmed">24567418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davido B., Saleh-Mghir A., Laurent F., Danel C., Couzon F., Gatin L., Vandenesch F., Rasigade J.-P., Crémieux A.-C. Phenol-Soluble Modulins Contribute to Early Sepsis Dissemination Not Late Local Usa300-Osteomyelitis Severity in Rabbits. PLoS ONE. 2016;11:e0157133.  doi: 10.1371/journal.pone.0157133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0157133</ArticleId>
            <ArticleId IdType="pmc">PMC4898696</ArticleId>
            <ArticleId IdType="pubmed">27275944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richardson J.R., Armbruster N.S., Günter M., Biljecki M., Klenk J., Heumos S., Autenrieth S.E. PSM Peptides from Community-Associated Methicillin-Resistant Staphylococcus aureus Impair the Adaptive Immune Response via Modulation of Dendritic Cell Subsets in Vivo. Front. Immunol. 2019;10:995. doi: 10.3389/fimmu.2019.00995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2019.00995</ArticleId>
            <ArticleId IdType="pmc">PMC6524657</ArticleId>
            <ArticleId IdType="pubmed">31134074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czech A., Yamaguchi T., Bader L., Linder S., Kaminski K., Sugai M., Aepfelbacher M. Prevalence of Rho-Inactivating Epidermal Cell Differentiation Inhibitor Toxins in Clinical Staphylococcus aureus Isolates. J. Infect. Dis. 2001;184:785–788. doi: 10.1086/322983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/322983</ArticleId>
            <ArticleId IdType="pubmed">11517442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Messad N., Landraud L., Canivet B., Lina G., Richard J.-L., Sotto A., Lavigne J.-P., Lemichez E. Distribution of Edin in Staphylococcus aureus Isolated from Diabetic Foot Ulcers. Clin. Microbiol. Infect. 2013;19:875–880. doi: 10.1111/1469-0691.12084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1469-0691.12084</ArticleId>
            <ArticleId IdType="pubmed">23176291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyer L., Doye A., Rolando M., Flatau G., Munro P., Gounon P., Clément R., Pulcini C., Popoff M.R., Mettouchi A., et al.  Induction of Transient Macroapertures in Endothelial Cells through RhoA Inhibition by Staphylococcus aureus Factors. J. Cell Biol. 2006;173:809–819. doi: 10.1083/jcb.200509009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200509009</ArticleId>
            <ArticleId IdType="pmc">PMC2063895</ArticleId>
            <ArticleId IdType="pubmed">16754962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aktories K., Lang A.E., Schwan C., Mannherz H.G. Actin as Target for Modification by Bacterial Protein Toxins. FEBS J. 2011;278:4526–4543. doi: 10.1111/j.1742-4658.2011.08113.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1742-4658.2011.08113.x</ArticleId>
            <ArticleId IdType="pubmed">21466657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaffe A.B., Hall A. Rho GTPases: Biochemistry and Biology. Annu. Rev. Cell Dev. Biol. 2005;21:247–269. doi: 10.1146/annurev.cellbio.21.020604.150721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.cellbio.21.020604.150721</ArticleId>
            <ArticleId IdType="pubmed">16212495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nusrat A., Giry M., Turner J.R., Colgan S.P., Parkos C.A., Carnes D., Lemichez E., Boquet P., Madara J.L. Rho Protein Regulates Tight Junctions and Perijunctional Actin Organization in Polarized Epithelia. Proc. Natl. Acad. Sci. USA. 1995;92:10629–10633. doi: 10.1073/pnas.92.23.10629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.92.23.10629</ArticleId>
            <ArticleId IdType="pmc">PMC40665</ArticleId>
            <ArticleId IdType="pubmed">7479854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caron E., Hall A. Identification of Two Distinct Mechanisms of Phagocytosis Controlled by Different Rho GTPases. Science. 1998;282:1717–1721. doi: 10.1126/science.282.5394.1717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.282.5394.1717</ArticleId>
            <ArticleId IdType="pubmed">9831565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemichez E., Lecuit M., Nassif X., Bourdoulous S. Breaking the Wall: Targeting of the Endothelium by Pathogenic Bacteria. Nat. Rev. Microbiol. 2010;8:93–104. doi: 10.1038/nrmicro2269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro2269</ArticleId>
            <ArticleId IdType="pubmed">20040916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards A.M., Massey R.C. How Does Staphylococcus aureus Escape the Bloodstream? Trends Microbiol. 2011;19:184–190. doi: 10.1016/j.tim.2010.12.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2010.12.005</ArticleId>
            <ArticleId IdType="pubmed">21227700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sugai M., Enomoto T., Hashimoto K., Matsumoto K., Matsuo Y., Ohgai H., Hong Y.-M., Inoue S., Yoshikawa K., Suginaka H. A Novel Epidermal Cell Differentiation Inhibitor (EDIN): Purification and Characterization from Staphylococcus aureus. Biochem. Biophys. Res. Commun. 1990;173:92–98. doi: 10.1016/S0006-291X(05)81026-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0006-291X(05)81026-5</ArticleId>
            <ArticleId IdType="pubmed">2256941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi T., Hayashi T., Takami H., Ohnishi M., Murata T., Nakayama K., Asakawa K., Ohara M., Komatsuzawa H., Sugai M. Complete Nucleotide Sequence of a Staphylococcus aureus Exfoliative Toxin B Plasmid and Identification of a Novel ADP-Ribosyltransferase, EDIN-C. Infect. Immun. 2001;69:7760–7771. doi: 10.1128/IAI.69.12.7760-7771.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.12.7760-7771.2001</ArticleId>
            <ArticleId IdType="pmc">PMC98872</ArticleId>
            <ArticleId IdType="pubmed">11705958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi T., Nishifuji K., Sasaki M., Fudaba Y., Aepfelbacher M., Takata T., Ohara M., Komatsuzawa H., Amagai M., Sugai M. Identification of the Staphylococcus aureus Etd Pathogenicity Island Which Encodes a Novel Exfoliative Toxin, ETD, and EDIN-B. Infect. Immun. 2002;70:5835–5845. doi: 10.1128/IAI.70.10.5835-5845.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.70.10.5835-5845.2002</ArticleId>
            <ArticleId IdType="pmc">PMC128317</ArticleId>
            <ArticleId IdType="pubmed">12228315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munro P., Benchetrit M., Nahori M.-A., Stefani C., Clément R., Michiels J.-F., Landraud L., Dussurget O., Lemichez E. The Staphylococcus aureus Epidermal Cell Differentiation Inhibitor Toxin Promotes Formation of Infection Foci in a Mouse Model of Bacteremia. Infect. Immun. 2010;78:3404–3411. doi: 10.1128/IAI.00319-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00319-10</ArticleId>
            <ArticleId IdType="pmc">PMC2916266</ArticleId>
            <ArticleId IdType="pubmed">20479081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antri K., Rouzic N., Boubekri I., Dauwalder O., Beloufa A., Ziane H., Djennane F., Neggazi M., Benhabyles B., Bes M., et al.  High prevalence of community and hospital acquired infections of methicillin-resistant Staphylococcus aureus containing Panton-Valentine leukocidin gene in Algiers. Pathol. Biol. 2010;58:e15–e20. doi: 10.1016/j.patbio.2009.07.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.patbio.2009.07.017</ArticleId>
            <ArticleId IdType="pubmed">19875247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Courjon J., Munro P., Benito Y., Visvikis O., Bouchiat C., Boyer L., Doye A., Lepidi H., Ghigo E., Lavigne J.-P., et al.  EDIN-B Promotes the Translocation of Staphylococcus aureus to the Bloodstream in the Course of Pneumonia. Toxins. 2015;7:4131–4142. doi: 10.3390/toxins7104131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins7104131</ArticleId>
            <ArticleId IdType="pmc">PMC4626725</ArticleId>
            <ArticleId IdType="pubmed">26501320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérez-Montarelo D., Viedma E., Larrosa N., Gómez-González C., Ruiz de Gopegui E., Muñoz-Gallego I., San Juan R., Fernández-Hidalgo N., Almirante B., Chaves F. Molecular Epidemiology of Staphylococcus aureus Bacteremia: Association of Molecular Factors With the Source of Infection. Front. Microbiol. 2018;9:2210. doi: 10.3389/fmicb.2018.02210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2018.02210</ArticleId>
            <ArticleId IdType="pmc">PMC6167439</ArticleId>
            <ArticleId IdType="pubmed">30319561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bukowski M., Wladyka B., Dubin G. Exfoliative Toxins of Staphylococcus aureus. Toxins. 2010;2:1148–1165. doi: 10.3390/toxins2051148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins2051148</ArticleId>
            <ArticleId IdType="pmc">PMC3153237</ArticleId>
            <ArticleId IdType="pubmed">22069631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanley J.R., Amagai M. Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome. N. Engl. J. Med. 2006;355:1800–1810. doi: 10.1056/NEJMra061111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra061111</ArticleId>
            <ArticleId IdType="pubmed">17065642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kato F., Kadomoto N., Iwamoto Y., Bunai K., Komatsuzawa H., Sugai M. Regulatory Mechanism for Exfoliative Toxin Production in Staphylococcus aureus. Infect. Immun. 2011;79:1660–1670. doi: 10.1128/IAI.00872-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00872-10</ArticleId>
            <ArticleId IdType="pmc">PMC3067547</ArticleId>
            <ArticleId IdType="pubmed">21282415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eyre R.W., Stanley J.R. Human Autoantibodies against a Desmosomal Protein Complex with a Calcium-Sensitive Epitope Are Characteristic of Pemphigus Foliaceus Patients. J. Exp. Med. 1987;165:1719–1724. doi: 10.1084/jem.165.6.1719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.165.6.1719</ArticleId>
            <ArticleId IdType="pmc">PMC2188354</ArticleId>
            <ArticleId IdType="pubmed">2438368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanakawa Y., Schechter N.M., Lin C., Garza L., Li H., Yamaguchi T., Fudaba Y., Nishifuji K., Sugai M., Amagai M., et al.  Molecular Mechanisms of Blister Formation in Bullous Impetigo and Staphylococcal Scalded Skin Syndrome. J. Clin. Investig. 2002;110:53–60. doi: 10.1172/JCI0215766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI0215766</ArticleId>
            <ArticleId IdType="pmc">PMC151035</ArticleId>
            <ArticleId IdType="pubmed">12093888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishifuji K., Sugai M., Amagai M. Staphylococcal Exfoliative Toxins: “Molecular Scissors” of Bacteria That Attack the Cutaneous Defense Barrier in Mammals. J. Dermatol. Sci. 2008;49:21–31. doi: 10.1016/j.jdermsci.2007.05.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jdermsci.2007.05.007</ArticleId>
            <ArticleId IdType="pubmed">17582744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sila J., Sauer P., Kolar M. Comparison of the Prevalence of Genes Coding for Enterotoxins, Exfoliatins, Panton-Valentine Leukocidin and Tsst-1 between Methicillin-Resistant and Methicillin-Susceptible Isolates of Staphylococcus aureus at the University Hospital in Olomouc. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czechoslov. 2009;153:215–218. doi: 10.5507/bp.2009.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5507/bp.2009.036</ArticleId>
            <ArticleId IdType="pubmed">19851435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mégevand C., Gervaix A., Heininger U., Berger C., Aebi C., Vaudaux B., Kind C., Gnehm H.-P., Hitzler M., Renzi G., et al.  Molecular Epidemiology of the Nasal Colonization by Methicillin-Susceptible Staphylococcus aureus in Swiss Children. Clin. Microbiol. Infect. 2010;16:1414–1420. doi: 10.1111/j.1469-0691.2009.03090.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2009.03090.x</ArticleId>
            <ArticleId IdType="pubmed">19845693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi T., Yokota Y., Terajima J., Hayashi T., Aepfelbacher M., Ohara M., Komatsuzawa H., Watanabe H., Sugai M. Clonal Association of Staphylococcus aureus Causing Bullous Impetigo and the Emergence of New Methicillin-Resistant Clonal Groups in Kansai District in Japan. J. Infect. Dis. 2002;185:1511–1516. doi: 10.1086/340212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/340212</ArticleId>
            <ArticleId IdType="pubmed">11992289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noguchi N., Nakaminami H., Nishijima S., Kurokawa I., So H., Sasatsu M. Antimicrobial Agent of Susceptibilities and Antiseptic Resistance Gene Distribution among Methicillin-Resistant Staphylococcus aureus Isolates from Patients with Impetigo and Staphylococcal Scalded Skin Syndrome. J. Clin. Microbiol. 2006;44:2119–2125. doi: 10.1128/JCM.02690-05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02690-05</ArticleId>
            <ArticleId IdType="pmc">PMC1489400</ArticleId>
            <ArticleId IdType="pubmed">16757607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wieczorek M., Abualrous E.T., Sticht J., Álvaro-Benito M., Stolzenberg S., Noé F., Freund C. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation. Front. Immunol. 2017;8:292. doi: 10.3389/fimmu.2017.00292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.00292</ArticleId>
            <ArticleId IdType="pmc">PMC5355494</ArticleId>
            <ArticleId IdType="pubmed">28367149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fraser J.D., Proft T. The Bacterial Superantigen and Superantigen-like Proteins. Immunol. Rev. 2008;225:226–243. doi: 10.1111/j.1600-065X.2008.00681.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-065X.2008.00681.x</ArticleId>
            <ArticleId IdType="pubmed">18837785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lina G., Bohach G.A., Nair S.P., Hiramatsu K., Jouvin-Marche E., Mariuzza R. Standard Nomenclature for the Superantigens Expressed by Staphylococcus. J. Infect. Dis. 2004;189:2334–2336. doi: 10.1086/420852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/420852</ArticleId>
            <ArticleId IdType="pubmed">15181583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hennekinne J.-A., De Buyser M.-L., Dragacci S. Staphylococcus aureus and Its Food Poisoning Toxins: Characterization and Outbreak Investigation. FEMS Microbiol. Rev. 2012;36:815–836. doi: 10.1111/j.1574-6976.2011.00311.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6976.2011.00311.x</ArticleId>
            <ArticleId IdType="pubmed">22091892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otto M. Staphylococcus aureus Toxins. Curr. Opin. Microbiol. 2014;17:32–37. doi: 10.1016/j.mib.2013.11.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mib.2013.11.004</ArticleId>
            <ArticleId IdType="pmc">PMC3942668</ArticleId>
            <ArticleId IdType="pubmed">24581690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu D.-L., Li S., Fang R., Ono H.K. Update on Molecular Diversity and Multipathogenicity of Staphylococcal Superantigen Toxins. Anim. Dis. 2021;1:7. doi: 10.1186/s44149-021-00007-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s44149-021-00007-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kong C., Neoh H., Nathan S. Targeting Staphylococcus aureus Toxins: A Potential Form of Anti-Virulence Therapy. Toxins. 2016;8:72.  doi: 10.3390/toxins8030072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins8030072</ArticleId>
            <ArticleId IdType="pmc">PMC4810217</ArticleId>
            <ArticleId IdType="pubmed">26999200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fisher E.L., Otto M., Cheung G.Y.C. Basis of Virulence in Enterotoxin-Mediated Staphylococcal Food Poisoning. Front. Microbiol. 2018;9:436. doi: 10.3389/fmicb.2018.00436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2018.00436</ArticleId>
            <ArticleId IdType="pmc">PMC5890119</ArticleId>
            <ArticleId IdType="pubmed">29662470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uchiyama T., Araake M., Yan X.J., Miyanaga Y., Igarashi H. Involvement of HLA Class II Molecules in Acquisition of Staphylococcal Enterotoxin A-Binding Activity and Accessory Cell Activity in Activation of Human T Cells by Related Toxins in Vascular Endothelial Cells. Clin. Exp. Immunol. 1992;87:322–328. doi: 10.1111/j.1365-2249.1992.tb02995.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2249.1992.tb02995.x</ArticleId>
            <ArticleId IdType="pmc">PMC1554270</ArticleId>
            <ArticleId IdType="pubmed">1735196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pezato R., Świerczyńska-Krępa M., Niżankowska-Mogilnicka E., Derycke L., Bachert C., Pérez-Novo C.A. Role of Imbalance of Eicosanoid Pathways and Staphylococcal Superantigens in Chronic Rhinosinusitis. Allergy. 2012;67:1347–1356. doi: 10.1111/all.12010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/all.12010</ArticleId>
            <ArticleId IdType="pubmed">22978320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinchuk I.V., Beswick E.J., Reyes V.E. Staphylococcal Enterotoxins. Toxins. 2010;2:2177–2197. doi: 10.3390/toxins2082177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins2082177</ArticleId>
            <ArticleId IdType="pmc">PMC3153290</ArticleId>
            <ArticleId IdType="pubmed">22069679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salgado-Pabón W., Breshears L., Spaulding A.R., Merriman J.A., Stach C.S., Horswill A.R., Peterson M.L., Schlievert P.M. Superantigens Are Critical for Staphylococcus aureus Infective Endocarditis, Sepsis, and Acute Kidney Injury. MBio. 2013;4:e00494-13. doi: 10.1128/mBio.00494-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00494-13</ArticleId>
            <ArticleId IdType="pmc">PMC3747586</ArticleId>
            <ArticleId IdType="pubmed">23963178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stach C.S., Herrera A., Schlievert P.M. Staphylococcal Superantigens Interact with Multiple Host Receptors to Cause Serious Diseases. Immunol. Res. 2014;59:177–181. doi: 10.1007/s12026-014-8539-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12026-014-8539-7</ArticleId>
            <ArticleId IdType="pmc">PMC4125451</ArticleId>
            <ArticleId IdType="pubmed">24838262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic Shock Syndrome and Bacterial Superantigens: An Update. Annu. Rev. Microbiol. 2001;55:77–104. doi: 10.1146/annurev.micro.55.1.77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.micro.55.1.77</ArticleId>
            <ArticleId IdType="pubmed">11544350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adhikari R.P., Ajao A.O., Aman M.J., Karauzum H., Sarwar J., Lydecker A.D., Johnson J.K., Nguyen C., Chen W.H., Roghmann M.-C. Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections. J. Infect. Dis. 2012;206:915–923. doi: 10.1093/infdis/jis462.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jis462</ArticleId>
            <ArticleId IdType="pubmed">22807524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma-Kuinkel B.K., Tkaczyk C., Bonnell J., Yu L., Tovchigrechko A., Tabor D.E., Park L.P., Ruffin F., Esser M.T., Sellman B.R., et al.  Associations of Pathogen-Specific and Host-Specific Characteristics with Disease Outcome in Patients with Staphylococcus aureus Bacteremic Pneumonia. Clin. Transl. Immunol. 2019;8:e01070. doi: 10.1002/cti2.1070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cti2.1070</ArticleId>
            <ArticleId IdType="pmc">PMC6640002</ArticleId>
            <ArticleId IdType="pubmed">31360464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gillet Y., Issartel B., Vanhems P., Fournet J.-C., Lina G., Bes M., Vandenesch F., Piémont Y., Brousse N., Floret D., et al.  Association between Staphylococcus aureus Strains Carrying Gene for Panton-Valentine Leukocidin and Highly Lethal Necrotising Pneumonia in Young Immunocompetent Patients. Lancet. 2002;359:753–759. doi: 10.1016/S0140-6736(02)07877-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(02)07877-7</ArticleId>
            <ArticleId IdType="pubmed">11888586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verdon J., Girardin N., Lacombe C., Berjeaud J.-M., Héchard Y. Delta-Hemolysin, an Update on a Membrane-Interacting Peptide. Peptides. 2009;30:817–823. doi: 10.1016/j.peptides.2008.12.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.peptides.2008.12.017</ArticleId>
            <ArticleId IdType="pubmed">19150639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surewaard B.G.J., de Haas C.J.C., Vervoort F., Rigby K.M., DeLeo F.R., Otto M., van Strijp J.A.G., Nijland R. Staphylococcal Alpha-Phenol Soluble Modulins Contribute to Neutrophil Lysis after Phagocytosis. Cell. Microbiol. 2013;15:1427–1437. doi: 10.1111/cmi.12130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.12130</ArticleId>
            <ArticleId IdType="pmc">PMC4784422</ArticleId>
            <ArticleId IdType="pubmed">23470014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra A.K., Yadav P., Mishra A. A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates. Open Microbiol. J. 2016;10:150. doi: 10.2174/1874285801610010150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1874285801610010150</ArticleId>
            <ArticleId IdType="pmc">PMC5012080</ArticleId>
            <ArticleId IdType="pubmed">27651848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilke G.A., Bubeck Wardenburg J. Role of a Disintegrin and Metalloprotease 10 in Staphylococcus aureus Alpha-Hemolysin-Mediated Cellular Injury. Proc. Natl. Acad. Sci. USA. 2010;107:13473–13478. doi: 10.1073/pnas.1001815107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1001815107</ArticleId>
            <ArticleId IdType="pmc">PMC2922128</ArticleId>
            <ArticleId IdType="pubmed">20624979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foletti D., Strop P., Shaughnessy L., Hasa-Moreno A., Casas M.G., Russell M., Bee C., Wu S., Pham A., Zeng Z., et al.  Mechanism of Action and in Vivo Efficacy of a Human-Derived Antibody against Staphylococcus aureus α-Hemolysin. J. Mol. Biol. 2013;425:1641–1654. doi: 10.1016/j.jmb.2013.02.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmb.2013.02.008</ArticleId>
            <ArticleId IdType="pubmed">23416200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oganesyan V., Peng L., Damschroder M.M., Cheng L., Sadowska A., Tkaczyk C., Sellman B.R., Wu H., Dall’Acqua W.F. Mechanisms of Neutralization of a Human Anti-α-Toxin Antibody. J. Biol. Chem. 2014;289:29874–29880. doi: 10.1074/jbc.M114.601328.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.601328</ArticleId>
            <ArticleId IdType="pmc">PMC4207998</ArticleId>
            <ArticleId IdType="pubmed">25210036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le V.T.M., Tkaczyk C., Chau S., Rao R.L., Dip E.C., Pereira-Franchi E.P., Cheng L., Lee S., Koelkebeck H., Hilliard J.J., et al.  Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections. Antimicrob. Agents Chemother. 2016;60:5640–5648. doi: 10.1128/AAC.00710-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00710-16</ArticleId>
            <ArticleId IdType="pmc">PMC5038308</ArticleId>
            <ArticleId IdType="pubmed">27401576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ortines R.V., Liu H., Cheng L.I., Cohen T.S., Lawlor H., Gami A., Wang Y., Dillen C.A., Archer N.K., Miller R.J., et al.  Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice. Antimicrob. Agents Chemother. 2018;62:e02288-17. doi: 10.1128/AAC.02288-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.02288-17</ArticleId>
            <ArticleId IdType="pmc">PMC5826123</ArticleId>
            <ArticleId IdType="pubmed">29311091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Surewaard B.G.J., Thanabalasuriar A., Zeng Z., Tkaczyk C., Cohen T.S., Bardoel B.W., Jorch S.K., Deppermann C., Bubeck Wardenburg J., Davis R.P., et al.  α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis. Cell Host Microbe. 2018;24:271–284.e3. doi: 10.1016/j.chom.2018.06.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2018.06.017</ArticleId>
            <ArticleId IdType="pmc">PMC6295203</ArticleId>
            <ArticleId IdType="pubmed">30033122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu X.-Q., Robbie G.J., Wu Y., Esser M.T., Jensen K., Schwartz H.I., Bellamy T., Hernandez-Illas M., Jafri H.S. Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults. Antimicrob. Agents Chemother. 2017;61:e01020-16. doi: 10.1128/AAC.01020-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01020-16</ArticleId>
            <ArticleId IdType="pmc">PMC5192133</ArticleId>
            <ArticleId IdType="pubmed">27795368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>François B., Jafri H.S., Chastre J., Sánchez-García M., Eggimann P., Dequin P.-F., Huberlant V., Viña Soria L., Boulain T., Bretonnière C., et al.  Efficacy and Safety of Suvratoxumab for Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia (SAATELLITE): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Pilot Trial. Lancet Infect. Dis. 2021;21:1313–1323. doi: 10.1016/S1473-3099(20)30995-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(20)30995-6</ArticleId>
            <ArticleId IdType="pubmed">33894131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>François B., Mercier E., Gonzalez C., Asehnoune K., Nseir S., Fiancette M., Desachy A., Plantefève G., Meziani F., de Lame P.-A., et al.  Safety and Tolerability of a Single Administration of AR-301, a Human Monoclonal Antibody, in ICU Patients with Severe Pneumonia Caused by Staphylococcus aureus: First-in-Human Trial. Intensive Care Med. 2018;44:1787–1796. doi: 10.1007/s00134-018-5229-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-018-5229-2</ArticleId>
            <ArticleId IdType="pubmed">30343314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Magyarics Z., Leslie F., Bartko J., Rouha H., Luperchio S., Schörgenhofer C., Schwameis M., Derhaschnig U., Lagler H., Stiebellehner L., et al.  Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers. Antimicrob. Agents Chemother. 2019;63:e00350-19. doi: 10.1128/AAC.00350-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00350-19</ArticleId>
            <ArticleId IdType="pmc">PMC6658777</ArticleId>
            <ArticleId IdType="pubmed">31138568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzin A., Yu L., Barraud O., François B., Sánchez Garcia M., Eggimann P., Dequin P.-F., Laterre P.-F., Huberlant V., Viña L., et al.  2160. Performance of the Cepheid Rapid PCR Test for Patient Screening and Association with Efficacy of Suvratoxumab, A Novel Anti-Staphylococcus aureus Monoclonal Antibody, During the Phase 2 SAATELLITE Study. Open Forum Infect. Dis. 2019;6:S733. doi: 10.1093/ofid/ofz360.1840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ofid/ofz360.1840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., Liassine N., Bes M., Greenland T., Reverdy M.-E., et al.  Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence. Emerg. Infect. Dis. 2003;9:978–984. doi: 10.3201/eid0908.030089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid0908.030089</ArticleId>
            <ArticleId IdType="pmc">PMC3020611</ArticleId>
            <ArticleId IdType="pubmed">12967497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diep B.A., Otto M. The Role of Virulence Determinants in Community-Associated MRSA Pathogenesis. Trends Microbiol. 2008;16:361–369. doi: 10.1016/j.tim.2008.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2008.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC2778837</ArticleId>
            <ArticleId IdType="pubmed">18585915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hermos C.R., Yoong P., Pier G.B. High Levels of Antibody to Panton-Valentine Leukocidin Are Not Associated with Resistance to Staphylococcus aureus-Associated Skin and Soft-Tissue Infection. Clin. Infect. Dis. 2010;51:1138–1146. doi: 10.1086/656742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/656742</ArticleId>
            <ArticleId IdType="pmc">PMC2962716</ArticleId>
            <ArticleId IdType="pubmed">20946065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gauduchon V., Cozon G., Vandenesch F., Genestier A.-L., Eyssade N., Peyrol S., Etienne J., Lina G. Neutralization of Staphylococcus aureus Panton Valentine Leukocidin by Intravenous Immunoglobulin In Vitro. J. Infect. Dis. 2004;189:346–353. doi: 10.1086/380909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/380909</ArticleId>
            <ArticleId IdType="pubmed">14722901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mairpady Shambat S., Chen P., Nguyen Hoang A.T., Bergsten H., Vandenesch F., Siemens N., Lina G., Monk I.R., Foster T.J., Arakere G., et al.  Modelling Staphylococcal Pneumonia in a Human 3D Lung Tissue Model System Delineates Toxin-Mediated Pathology. Dis. Model. Mech. 2015;8:1413–1425. doi: 10.1242/dmm.021923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dmm.021923</ArticleId>
            <ArticleId IdType="pmc">PMC4631791</ArticleId>
            <ArticleId IdType="pubmed">26398950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rouzic N., Janvier F., Libert N., Javouhey E., Lina G., Nizou J.-Y., Pasquier P., Stamm D., Brinquin L., Pelletier C., et al.  Prompt and Successful Toxin-Targeting Treatment of Three Patients with Necrotizing Pneumonia Due to Staphylococcus aureus Strains Carrying the Panton-Valentine Leukocidin Genes. J. Clin. Microbiol. 2010;48:1952–1955. doi: 10.1128/JCM.01892-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01892-09</ArticleId>
            <ArticleId IdType="pmc">PMC2863892</ArticleId>
            <ArticleId IdType="pubmed">20129956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laventie B.-J., Rademaker H.J., Saleh M., de Boer E., Janssens R., Bourcier T., Subilia A., Marcellin L., van Haperen R., Lebbink J.H.G., et al.  Heavy Chain-Only Antibodies and Tetravalent Bispecific Antibody Neutralizing Staphylococcus aureus Leukotoxins. Proc. Natl. Acad. Sci. USA. 2011;108:16404–16409. doi: 10.1073/pnas.1102265108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1102265108</ArticleId>
            <ArticleId IdType="pmc">PMC3182740</ArticleId>
            <ArticleId IdType="pubmed">21930905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aman M.J. Superantigens of a Superbug: Major Culprits of Staphylococcus aureus Disease? Virulence. 2017;8:607–610. doi: 10.1080/21505594.2016.1255399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21505594.2016.1255399</ArticleId>
            <ArticleId IdType="pmc">PMC5626348</ArticleId>
            <ArticleId IdType="pubmed">27805458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drozdowski B., Zhou Y., Kline B., Spidel J., Chan Y.Y., Albone E., Turchin H., Chao Q., Henry M., Balogach J., et al.  Generation and Characterization of High Affinity Human Monoclonal Antibodies That Neutralize Staphylococcal Enterotoxin B. J. Immune Based Ther. Vaccines. 2010;8:9. doi: 10.1186/1476-8518-8-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1476-8518-8-9</ArticleId>
            <ArticleId IdType="pmc">PMC3022601</ArticleId>
            <ArticleId IdType="pubmed">21176153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varshney A.K., Wang X., Scharff M.D., MacIntyre J., Zollner R.S., Kovalenko O.V., Martinez L.R., Byrne F.R., Fries B.C. Staphylococcal Enterotoxin B-Specific Monoclonal Antibody 20B1 Successfully Treats Diverse Staphylococcus aureus Infections. J. Infect. Dis. 2013;208:2058–2066. doi: 10.1093/infdis/jit421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jit421</ArticleId>
            <ArticleId IdType="pmc">PMC3836467</ArticleId>
            <ArticleId IdType="pubmed">23922375</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang R.H., Luk B.T., Hu C.-M.J., Zhang L. Engineered Nanoparticles Mimicking Cell Membranes for Toxin Neutralization. Adv. Drug Deliv. Rev. 2015;90:69–80. doi: 10.1016/j.addr.2015.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.addr.2015.04.001</ArticleId>
            <ArticleId IdType="pmc">PMC4547889</ArticleId>
            <ArticleId IdType="pubmed">25868452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henry B.D., Neill D.R., Becker K.A., Gore S., Bricio-Moreno L., Ziobro R., Edwards M.J., Mühlemann K., Steinmann J., Kleuser B., et al.  Engineered Liposomes Sequester Bacterial Exotoxins and Protect from Severe Invasive Infections in Mice. Nat. Biotechnol. 2015;33:81–88. doi: 10.1038/nbt.3037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nbt.3037</ArticleId>
            <ArticleId IdType="pubmed">25362245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfmeier H., Mansour S.C., Liu L.T., Pletzer D., Draeger A., Babiychuk E.B., Hancock R.E.W. Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus aureus by Targeting α-Type Phenol-Soluble Modulins and α-Hemolysin. EBioMedicine. 2018;33:211–217. doi: 10.1016/j.ebiom.2018.06.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2018.06.016</ArticleId>
            <ArticleId IdType="pmc">PMC6085503</ArticleId>
            <ArticleId IdType="pubmed">29936135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keller M.D., Ching K.L., Liang F.-X., Dhabaria A., Tam K., Ueberheide B.M., Unutmaz D., Torres V.J., Cadwell K. Decoy Exosomes Provide Protection against Bacterial Toxins. Nature. 2020;579:260–264. doi: 10.1038/s41586-020-2066-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2066-6</ArticleId>
            <ArticleId IdType="pmc">PMC7519780</ArticleId>
            <ArticleId IdType="pubmed">32132711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y., Chen M., Zhang Y., Lee J.H., Escajadillo T., Gong H., Fang R.H., Gao W., Nizet V., Zhang L. Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges. Adv. Healthc. Mater. 2018;7:e1701366. doi: 10.1002/adhm.201701366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/adhm.201701366</ArticleId>
            <ArticleId IdType="pmc">PMC6041168</ArticleId>
            <ArticleId IdType="pubmed">29436150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei X., Gao J., Wang F., Ying M., Angsantikul P., Kroll A.V., Zhou J., Gao W., Lu W., Fang R.H., et al.  In Situ Capture of Bacterial Toxins for Antivirulence Vaccination. Adv. Mater. 2017;29:1701644. doi: 10.1002/adma.201701644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/adma.201701644</ArticleId>
            <ArticleId IdType="pmc">PMC5581250</ArticleId>
            <ArticleId IdType="pubmed">28656663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yarwood J.M., Bartels D.J., Volper E.M., Greenberg E.P. Quorum Sensing in Staphylococcus aureus Biofilms. J. Bacteriol. 2004;186:1838–1850. doi: 10.1128/JB.186.6.1838-1850.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.186.6.1838-1850.2004</ArticleId>
            <ArticleId IdType="pmc">PMC355980</ArticleId>
            <ArticleId IdType="pubmed">14996815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheung G.Y.C., Wang R., Khan B.A., Sturdevant D.E., Otto M. Role of the Accessory Gene Regulator Agr in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis. Infect. Immun. 2011;79:1927–1935. doi: 10.1128/IAI.00046-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00046-11</ArticleId>
            <ArticleId IdType="pmc">PMC3088142</ArticleId>
            <ArticleId IdType="pubmed">21402769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Novick R.P., Ross H.F., Projan S.J., Kornblum J., Kreiswirth B., Moghazeh S. Synthesis of Staphylococcal Virulence Factors Is Controlled by a Regulatory RNA Molecule. EMBO J. 1993;12:3967–3975. doi: 10.1002/j.1460-2075.1993.tb06074.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/j.1460-2075.1993.tb06074.x</ArticleId>
            <ArticleId IdType="pmc">PMC413679</ArticleId>
            <ArticleId IdType="pubmed">7691599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balaban N., Collins L.V., Cullor J.S., Hume E.B., Medina-Acosta E., Vieira da Motta O., O’Callaghan R., Rossitto P.V., Shirtliff M.E., Serafim da Silveira L., et al.  Prevention of Diseases Caused by Staphylococcus aureus Using the Peptide RIP. Peptides. 2000;21:1301–1311. doi: 10.1016/S0196-9781(00)00272-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0196-9781(00)00272-2</ArticleId>
            <ArticleId IdType="pubmed">11072116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gov Y., Bitler A., Dell’Acqua G., Torres J.V., Balaban N. RNAIII Inhibiting Peptide (RIP), a Global Inhibitor of Staphylococcus aureus Pathogenesis: Structure and Function Analysis. Peptides. 2001;22:1609–1620. doi: 10.1016/S0196-9781(01)00496-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0196-9781(01)00496-X</ArticleId>
            <ArticleId IdType="pubmed">11587789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vieira-da-Motta O., Damasceno Ribeiro P., Dias da Silva W., Medina-Acosta E. RNAIII Inhibiting Peptide (RIP) Inhibits Agr-Regulated Toxin Production. Peptides. 2001;22:1621–1627. doi: 10.1016/S0196-9781(01)00497-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0196-9781(01)00497-1</ArticleId>
            <ArticleId IdType="pubmed">11587790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B., Zhou Y., Li M., Yu Q., Xue X., Li Z., Da F., Hou Z., Luo X. RIP-V Improves Murine Survival in a Sepsis Model by down-Regulating RNAIII Expression and α-Hemolysin Release of Methicillin-Resistant Staphylococcus aureus. Pharmazie. 2015;70:81–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25997246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giacometti A., Cirioni O., Ghiselli R., Dell’Acqua G., Orlando F., D’Amato G., Mocchegiani F., Silvestri C., Del Prete M.S., Rocchi M., et al.  RNAIII-Inhibiting Peptide Improves Efficacy of Clinically Used Antibiotics in a Murine Model of Staphylococcal Sepsis. Peptides. 2005;26:169–175. doi: 10.1016/j.peptides.2004.09.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.peptides.2004.09.018</ArticleId>
            <ArticleId IdType="pubmed">15629527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simonetti O., Cirioni O., Ghiselli R., Goteri G., Scalise A., Orlando F., Silvestri C., Riva A., Saba V., Madanahally K.D., et al.  RNAIII-Inhibiting Peptide Enhances Healing of Wounds Infected with Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2008;52:2205–2211. doi: 10.1128/AAC.01340-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01340-07</ArticleId>
            <ArticleId IdType="pmc">PMC2415788</ArticleId>
            <ArticleId IdType="pubmed">18391046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y., Niu C., Ma B., Xue X., Li Z., Chen Z., Li F., Zhou S., Luo X., Hou Z. Inhibiting PSMα-Induced Neutrophil Necroptosis Protects Mice with MRSA Pneumonia by Blocking the Agr System. Cell Death Dis. 2018;9:362. doi: 10.1038/s41419-018-0398-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-018-0398-z</ArticleId>
            <ArticleId IdType="pmc">PMC5834619</ArticleId>
            <ArticleId IdType="pubmed">29500427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huan Y., Kong Q., Mou H., Yi H. Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front. Microbiol. 2020;11:2559. doi: 10.3389/fmicb.2020.582779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2020.582779</ArticleId>
            <ArticleId IdType="pmc">PMC7596191</ArticleId>
            <ArticleId IdType="pubmed">33178164</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kudryashova E., Seveau S.M., Kudryashov D.S. Targeting and Inactivation of Bacterial Toxins by Human Defensins. Biol. Chem. 2017;398:1069–1085. doi: 10.1515/hsz-2017-0106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/hsz-2017-0106</ArticleId>
            <ArticleId IdType="pmc">PMC5608644</ArticleId>
            <ArticleId IdType="pubmed">28593905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patrulea V., Borchard G., Jordan O. An Update on Antimicrobial Peptides (AMPs) and Their Delivery Strategies for Wound Infections. Pharmaceutics. 2020;12:840.  doi: 10.3390/pharmaceutics12090840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pharmaceutics12090840</ArticleId>
            <ArticleId IdType="pmc">PMC7560145</ArticleId>
            <ArticleId IdType="pubmed">32887353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lehrer R.I., Lu W. α-Defensins in Human Innate Immunity. Immunol. Rev. 2012;245:84–112. doi: 10.1111/j.1600-065X.2011.01082.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-065X.2011.01082.x</ArticleId>
            <ArticleId IdType="pubmed">22168415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lillard J.W., Boyaka P.N., Chertov O., Oppenheim J.J., McGhee J.R. Mechanisms for Induction of Acquired Host Immunity by Neutrophil Peptide Defensins. Proc. Natl. Acad. Sci. USA. 1999;96:651–656. doi: 10.1073/pnas.96.2.651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.96.2.651</ArticleId>
            <ArticleId IdType="pmc">PMC15191</ArticleId>
            <ArticleId IdType="pubmed">9892688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diep B.A., Chan L., Tattevin P., Kajikawa O., Martin T.R., Basuino L., Mai T.T., Marbach H., Braughton K.R., Whitney A.R., et al.  Polymorphonuclear Leukocytes Mediate Staphylococcus aureus Panton-Valentine Leukocidin-Induced Lung Inflammation and Injury. Proc. Natl. Acad. Sci. USA. 2010;107:5587–5592. doi: 10.1073/pnas.0912403107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0912403107</ArticleId>
            <ArticleId IdType="pmc">PMC2851770</ArticleId>
            <ArticleId IdType="pubmed">20231457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardot-Martin E., Casalegno J.S., Badiou C., Dauwalder O., Keller D., Prévost G., Rieg S., Kern W.V., Cuerq C., Etienne J., et al.  α-Defensins Partially Protect Human Neutrophils against Panton-Valentine Leukocidin Produced by Staphylococcus aureus. Lett. Appl. Microbiol. 2015;61:158–164. doi: 10.1111/lam.12438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/lam.12438</ArticleId>
            <ArticleId IdType="pubmed">25963798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karginov V.A., Nestorovich E.M., Schmidtmann F., Robinson T.M., Yohannes A., Fahmi N.E., Bezrukov S.M., Hecht S.M. Inhibition of S. aureus α-Hemolysin and B. anthracis Lethal Toxin by β-Cyclodextrin Derivatives. Bioorg. Med. Chem. 2007;15:5424–5431. doi: 10.1016/j.bmc.2007.05.058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bmc.2007.05.058</ArticleId>
            <ArticleId IdType="pmc">PMC2139893</ArticleId>
            <ArticleId IdType="pubmed">17572091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong J., Qiu J., Wang J., Li H., Dai X., Zhang Y., Wang X., Tan W., Niu X., Deng X., et al.  Apigenin Alleviates the Symptoms of Staphylococcus aureus Pneumonia by Inhibiting the Production of Alpha-Hemolysin. FEMS Microbiol. Lett. 2013;338:124–131. doi: 10.1111/1574-6968.12040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1574-6968.12040</ArticleId>
            <ArticleId IdType="pubmed">23113475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang L., Yi T., Shen Z., Teng Z., Wang J. Aloe-Emodin Attenuates Staphylococcus aureus Pathogenicity by Interfering with the Oligomerization of α-Toxin. Front. Cell. Infect. Microbiol. 2019;9:157. doi: 10.3389/fcimb.2019.00157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2019.00157</ArticleId>
            <ArticleId IdType="pmc">PMC6530610</ArticleId>
            <ArticleId IdType="pubmed">31157174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J., Zhou X., Liu S., Li G., Shi L., Dong J., Li W., Deng X., Niu X. Morin Hydrate Attenuates Staphylococcus aureus Virulence by Inhibiting the Self-Assembly of α-Hemolysin. J. Appl. Microbiol. 2015;118:753–763. doi: 10.1111/jam.12743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jam.12743</ArticleId>
            <ArticleId IdType="pubmed">25564958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong J., Qiu J., Zhang Y., Lu C., Dai X., Wang J., Li H., Wang X., Tan W., Luo M., et al.  Oroxylin A Inhibits Hemolysis via Hindering the Self-Assembly of α-Hemolysin Heptameric Transmembrane Pore. PLoS Comput. Biol. 2013;9:e1002869.  doi: 10.1371/journal.pcbi.1002869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pcbi.1002869</ArticleId>
            <ArticleId IdType="pmc">PMC3547825</ArticleId>
            <ArticleId IdType="pubmed">23349625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu J., Wang D., Zhang Y., Dong J., Wang J., Niu X. Molecular Modeling Reveals the Novel Inhibition Mechanism and Binding Mode of Three Natural Compounds to Staphylococcal α-Hemolysin. PLoS ONE. 2013;8:e80197.  doi: 10.1371/journal.pone.0080197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0080197</ArticleId>
            <ArticleId IdType="pmc">PMC3842302</ArticleId>
            <ArticleId IdType="pubmed">24312202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman M., Rasooly R., Do P.M., Henika P.R. The Olive Compound 4-Hydroxytyrosol Inactivates Staphylococcus aureus Bacteria and Staphylococcal Enterotoxin A (SEA) J. Food Sci. 2011;76:M558–M563. doi: 10.1111/j.1750-3841.2011.02365.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1750-3841.2011.02365.x</ArticleId>
            <ArticleId IdType="pubmed">22417596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mansson M., Nielsen A., Kjærulff L., Gotfredsen C.H., Wietz M., Ingmer H., Gram L., Larsen T.O. Inhibition of Virulence Gene Expression in Staphylococcus aureus by Novel Depsipeptides from a Marine Photobacterium. Mar. Drugs. 2011;9:2537–2552. doi: 10.3390/md9122537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/md9122537</ArticleId>
            <ArticleId IdType="pmc">PMC3280567</ArticleId>
            <ArticleId IdType="pubmed">22363239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nielsen A., Månsson M., Bojer M.S., Gram L., Larsen T.O., Novick R.P., Frees D., Frøkiær H., Ingmer H. Solonamide B Inhibits Quorum Sensing and Reduces Staphylococcus aureus Mediated Killing of Human Neutrophils. PLoS ONE. 2014;9:e84992.  doi: 10.1371/journal.pone.0084992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0084992</ArticleId>
            <ArticleId IdType="pmc">PMC3885660</ArticleId>
            <ArticleId IdType="pubmed">24416329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baldry M., Kitir B., Frøkiær H., Christensen S.B., Taverne N., Meijerink M., Franzyk H., Olsen C.A., Wells J.M., Ingmer H. The Agr Inhibitors Solonamide B and Analogues Alter Immune Responses to Staphylococcus aureus but Do Not Exhibit Adverse Effects on Immune Cell Functions. PLoS ONE. 2016;11:e0145618.  doi: 10.1371/journal.pone.0145618.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0145618</ArticleId>
            <ArticleId IdType="pmc">PMC4701192</ArticleId>
            <ArticleId IdType="pubmed">26731096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baldry M., Nakamura Y., Nakagawa S., Frees D., Matsue H., Núñez G., Ingmer H. Application of an Agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease. J. Infect. Dis. 2018;218:1009–1013. doi: 10.1093/infdis/jiy259.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiy259</ArticleId>
            <ArticleId IdType="pmc">PMC6093339</ArticleId>
            <ArticleId IdType="pubmed">29733353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J., Qiu J., Dong J., Li H., Luo M., Dai X., Zhang Y., Leng B., Niu X., Zhao S., et al.  Chrysin Protects Mice from Staphylococcus aureus Pneumonia. J. Appl. Microbiol. 2011;111:1551–1558. doi: 10.1111/j.1365-2672.2011.05170.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2672.2011.05170.x</ArticleId>
            <ArticleId IdType="pubmed">21972890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang F., Li W.-H., Zhou X., Liu Y.-H., Li Z., Tang Y.-S., Kou X., Wang S.-D., Bao M., Qu L.-D., et al.  Puerarin Protects against Staphylococcus aureus-Induced Injury of Human Alveolar Epithelial A549 Cells via Downregulating Alpha-Hemolysin Secretion. Microb. Drug Resist. 2014;20:357–363. doi: 10.1089/mdr.2013.0104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.2013.0104</ArticleId>
            <ArticleId IdType="pubmed">24372183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang L., Li H., Wang L., Song Z., Shi L., Li W., Deng X., Wang J. Isorhamnetin Attenuates Staphylococcus aureus-Induced Lung Cell Injury by Inhibiting Alpha-Hemolysin Expression. J. Microbiol. Biotechnol. 2016;26:596–602. doi: 10.4014/jmb.1507.07091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4014/jmb.1507.07091</ArticleId>
            <ArticleId IdType="pubmed">26643966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nabavi S.F., Braidy N., Habtemariam S., Orhan I.E., Daglia M., Manayi A., Gortzi O., Nabavi S.M. Neuroprotective Effects of Chrysin: From Chemistry to Medicine. Neurochem. Int. 2015;90:224–231. doi: 10.1016/j.neuint.2015.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuint.2015.09.006</ArticleId>
            <ArticleId IdType="pubmed">26386393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y.-X., Zhang H., Peng C. Puerarin: A Review of Pharmacological Effects. Phytother. Res. PTR. 2014;28:961–975. doi: 10.1002/ptr.5083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ptr.5083</ArticleId>
            <ArticleId IdType="pubmed">24339367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y., Wang J.-F., Dong J., Wei J.-Y., Wang Y.-N., Dai X.-H., Wang X., Luo M.-J., Tan W., Deng X.-M., et al.  Inhibition of α-Toxin Production by Subinhibitory Concentrations of Naringenin Controls Staphylococcus aureus Pneumonia. Fitoterapia. 2013;86:92–99. doi: 10.1016/j.fitote.2013.02.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fitote.2013.02.001</ArticleId>
            <ArticleId IdType="pubmed">23425602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salehi B., Fokou P.V.T., Sharifi-Rad M., Zucca P., Pezzani R., Martins N., Sharifi-Rad J. The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Pharmaceuticals. 2019;12:11.  doi: 10.3390/ph12010011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ph12010011</ArticleId>
            <ArticleId IdType="pmc">PMC6469163</ArticleId>
            <ArticleId IdType="pubmed">30634637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quave C.L., Plano L.R.W., Bennett B.C. Quorum Sensing Inhibitors of Staphylococcus aureus from Italian Medicinal Plants. Planta Med. 2011;77:188–195. doi: 10.1055/s-0030-1250145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1250145</ArticleId>
            <ArticleId IdType="pmc">PMC3022964</ArticleId>
            <ArticleId IdType="pubmed">20645243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muhs A., Lyles J.T., Parlet C.P., Nelson K., Kavanaugh J.S., Horswill A.R., Quave C.L. Virulence Inhibitors from Brazilian Peppertree Block Quorum Sensing and Abate Dermonecrosis in Skin Infection Models. Sci. Rep. 2017;7:42275. doi: 10.1038/srep42275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep42275</ArticleId>
            <ArticleId IdType="pmc">PMC5301492</ArticleId>
            <ArticleId IdType="pubmed">28186134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Todd D.A., Parlet C.P., Crosby H.A., Malone C.L., Heilmann K.P., Horswill A.R., Cech N.B. Signal Biosynthesis Inhibition with Ambuic Acid as a Strategy To Target Antibiotic-Resistant Infections. Antimicrob. Agents Chemother. 2017;61:e00263-17. doi: 10.1128/AAC.00263-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00263-17</ArticleId>
            <ArticleId IdType="pmc">PMC5527603</ArticleId>
            <ArticleId IdType="pubmed">28607020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geisinger E., Muir T.W., Novick R.P. Agr Receptor Mutants Reveal Distinct Modes of Inhibition by Staphylococcal Autoinducing Peptides. Proc. Natl. Acad. Sci. USA. 2009;106:1216–1221. doi: 10.1073/pnas.0807760106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0807760106</ArticleId>
            <ArticleId IdType="pmc">PMC2633565</ArticleId>
            <ArticleId IdType="pubmed">19147840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malachowa N., Kobayashi S.D., Braughton K.R., DeLeo F.R.  Mouse Models of Innate Immunity. Volume 1031. Humana Press; Totowa, NJ, USA: 2013. Mouse Model of Staphylococcus aureus Skin Infection; pp. 109–116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-62703-481-4_14</ArticleId>
            <ArticleId IdType="pubmed">23824894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menzies B.E., Kernodle D.S. Site-Directed Mutagenesis of the Alpha-Toxin Gene of Staphylococcus aureus: Role of Histidines in Toxin Activity in Vitro and in a Murine Model. Infect. Immun. 1994;62:1843–1847. doi: 10.1128/iai.62.5.1843-1847.1994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.62.5.1843-1847.1994</ArticleId>
            <ArticleId IdType="pmc">PMC186423</ArticleId>
            <ArticleId IdType="pubmed">8168947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bubeck Wardenburg J., Schneewind O. Vaccine Protection against Staphylococcus aureus Pneumonia. J. Exp. Med. 2008;205:287–294. doi: 10.1084/jem.20072208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20072208</ArticleId>
            <ArticleId IdType="pmc">PMC2271014</ArticleId>
            <ArticleId IdType="pubmed">18268041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karauzum H., Venkatasubramaniam A., Adhikari R.P., Kort T., Holtsberg F.W., Mukherjee I., Mednikov M., Ortines R., Nguyen N.T.Q., Doan T.M.N., et al.  IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus. Front. Immunol. 2021;12:624310. doi: 10.3389/fimmu.2021.624310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2021.624310</ArticleId>
            <ArticleId IdType="pmc">PMC7987673</ArticleId>
            <ArticleId IdType="pubmed">33777005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown E.L., Dumitrescu O., Thomas D., Badiou C., Koers E.M., Choudhury P., Vazquez V., Etienne J., Lina G., Vandenesch F., et al.  The Panton-Valentine Leukocidin Vaccine Protects Mice against Lung and Skin Infections Caused by Staphylococcus aureus USA300. Clin. Microbiol. Infect. 2009;15:156–164. doi: 10.1111/j.1469-0691.2008.02648.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2008.02648.x</ArticleId>
            <ArticleId IdType="pmc">PMC2657196</ArticleId>
            <ArticleId IdType="pubmed">19154186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karauzum H., Adhikari R.P., Sarwar J., Devi V.S., Abaandou L., Haudenschild C., Mahmoudieh M., Boroun A.R., Vu H., Nguyen T., et al.  Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model. PLoS ONE. 2013;8:e65384.  doi: 10.1371/journal.pone.0065384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0065384</ArticleId>
            <ArticleId IdType="pmc">PMC3676412</ArticleId>
            <ArticleId IdType="pubmed">23762356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landrum M.L., Lalani T., Niknian M., Maguire J.D., Hospenthal D.R., Fattom A., Taylor K., Fraser J., Wilkins K., Ellis M.W., et al.  Safety and Immunogenicity of a Recombinant Staphylococcus aureus α-Toxoid and a Recombinant Panton-Valentine Leukocidin Subunit, in Healthy Adults. Hum. Vaccines Immunother. 2017;13:791–801. doi: 10.1080/21645515.2016.1248326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2016.1248326</ArticleId>
            <ArticleId IdType="pmc">PMC5404372</ArticleId>
            <ArticleId IdType="pubmed">28010246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones T. StaphVAX (Nabi) Curr. Opin. Investig. Drugs Lond. Engl. 2000. 2002;3:48–50.</Citation>
        </Reference>
        <Reference>
          <Citation>Staphylococcus aureus Vaccine Conjugate–Nabi: Nabi-StaphVAX, StaphVAX. Drugs RD. 2003;4:383–385. doi: 10.2165/00126839-200304060-00013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00126839-200304060-00013</ArticleId>
            <ArticleId IdType="pubmed">14584973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asensi G.F., de Sales N.F.F., Dutra F.F., Feijó D.F., Bozza M.T., Ulrich R.G., Miyoshi A., de Morais K., Azevedo V.A.d.C., Silva J.T., et al.  Oral Immunization with Lactococcus lactis Secreting Attenuated Recombinant Staphylococcal Enterotoxin B Induces a Protective Immune Response in a Murine Model. Microb. Cell Fact. 2013;12:32. doi: 10.1186/1475-2859-12-32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1475-2859-12-32</ArticleId>
            <ArticleId IdType="pmc">PMC3623888</ArticleId>
            <ArticleId IdType="pubmed">23561053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W.H., Pasetti M.F., Adhikari R.P., Baughman H., Douglas R., El-Khorazaty J., Greenberg N., Holtsberg F.W., Liao G.C., Reymann M.K., et al.  Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax. Clin. Vaccine Immunol. 2016;23:918–925. doi: 10.1128/CVI.00399-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CVI.00399-16</ArticleId>
            <ArticleId IdType="pmc">PMC5139602</ArticleId>
            <ArticleId IdType="pubmed">27707765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu D.-L., Omoe K., Sasaki S., Sashinami H., Sakuraba H., Yokomizo Y., Shinagawa K., Nakane A. Vaccination with Nontoxic Mutant Toxic Shock Syndrome Toxin 1 Protects against Staphylococcus aureus Infection. J. Infect. Dis. 2003;188:743–752. doi: 10.1086/377308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/377308</ArticleId>
            <ArticleId IdType="pubmed">12934191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwameis M., Roppenser B., Firbas C., Gruener C.S., Model N., Stich N., Roetzer A., Buchtele N., Jilma B., Eibl M.M. Safety, Tolerability, and Immunogenicity of a Recombinant Toxic Shock Syndrome Toxin (RTSST)-1 Variant Vaccine: A Randomised, Double-Blind, Adjuvant-Controlled, Dose Escalation First-in-Man Trial. Lancet Infect. Dis. 2016;16:1036–1044. doi: 10.1016/S1473-3099(16)30115-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(16)30115-3</ArticleId>
            <ArticleId IdType="pubmed">27296693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roetzer A., Jilma B., Eibl M.M. Vaccine against Toxic Shock Syndrome in a First-in-Man Clinical Trial. Expert Rev. Vaccines. 2017;16:81–83. doi: 10.1080/14760584.2017.1268921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14760584.2017.1268921</ArticleId>
            <ArticleId IdType="pubmed">27918218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown L., Wolf J.M., Prados-Rosales R., Casadevall A. Through the Wall: Extracellular Vesicles in Gram-Positive Bacteria, Mycobacteria and Fungi. Nat. Rev. Microbiol. 2015;13:620–630. doi: 10.1038/nrmicro3480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro3480</ArticleId>
            <ArticleId IdType="pmc">PMC4860279</ArticleId>
            <ArticleId IdType="pubmed">26324094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X., Koffi P.F., English O.F., Lee J.C. Staphylococcus aureus Extracellular Vesicles: A Story of Toxicity and the Stress of 2020. Toxins. 2021;13:75.  doi: 10.3390/toxins13020075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins13020075</ArticleId>
            <ArticleId IdType="pmc">PMC7909408</ArticleId>
            <ArticleId IdType="pubmed">33498438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattis D.M., Spaulding A.R., Chuang-Smith O.N., Sundberg E.J., Schlievert P.M., Kranz D.M. Engineering a Soluble High-Affinity Receptor Domain That Neutralizes Staphylococcal Enterotoxin C in Rabbit Models of Disease. Protein Eng. Des. Sel. PEDS. 2013;26:133–142. doi: 10.1093/protein/gzs094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/protein/gzs094</ArticleId>
            <ArticleId IdType="pmc">PMC3542526</ArticleId>
            <ArticleId IdType="pubmed">23161916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X., Thompson C.D., Weidenmaier C., Lee J.C. Release of Staphylococcus aureus Extracellular Vesicles and Their Application as a Vaccine Platform. Nat. Commun. 2018;9:1379. doi: 10.1038/s41467-018-03847-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-03847-z</ArticleId>
            <ArticleId IdType="pmc">PMC5895597</ArticleId>
            <ArticleId IdType="pubmed">29643357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>da Silveira S.A., Perez A. Improving the Fate of Severely Infected Patients: The Promise of Anti-Toxin Treatments and Superiority Trials. Expert Rev. Anti Infect. Ther. 2017;15:973–975. doi: 10.1080/14787210.2017.1400908.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14787210.2017.1400908</ArticleId>
            <ArticleId IdType="pubmed">29098906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parker D. Humanized Mouse Models of Staphylococcus aureus Infection. Front. Immunol. 2017;8:512. doi: 10.3389/fimmu.2017.00512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.00512</ArticleId>
            <ArticleId IdType="pmc">PMC5415562</ArticleId>
            <ArticleId IdType="pubmed">28523002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen T.M., Brehm M.A., Bridges S., Ferguson S., Kumar P., Mirochnitchenko O., Palucka K., Pelanda R., Sanders-Beer B., Shultz L.D., et al.  Humanized Immune System Mouse Models: Progress, Challenges and Opportunities. Nat. Immunol. 2019;20:770–774. doi: 10.1038/s41590-019-0416-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41590-019-0416-z</ArticleId>
            <ArticleId IdType="pmc">PMC7265413</ArticleId>
            <ArticleId IdType="pubmed">31160798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mrochen D.M., Fernandes de Oliveira L.M., Raafat D., Holtfreter S. Staphylococcus aureus Host Tropism and Its Implications for Murine Infection Models. Int. J. Mol. Sci. 2020;21:7061.  doi: 10.3390/ijms21197061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21197061</ArticleId>
            <ArticleId IdType="pmc">PMC7582387</ArticleId>
            <ArticleId IdType="pubmed">32992784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan B.A., Yeh A.J., Cheung G.Y., Otto M. Investigational Therapies Targeting Quorum-Sensing for the Treatment of Staphylococcus aureus Infections. Expert Opin. Investig. Drugs. 2015;24:689–704. doi: 10.1517/13543784.2015.1019062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/13543784.2015.1019062</ArticleId>
            <ArticleId IdType="pmc">PMC6106785</ArticleId>
            <ArticleId IdType="pubmed">25704585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar K., Chen J., Drlica K., Shopsin B. Tuning of the Lethal Response to Multiple Stressors with a Single-Site Mutation during Clinical Infection by Staphylococcus aureus. MBio. 2017;8:e01476-17. doi: 10.1128/mBio.01476-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01476-17</ArticleId>
            <ArticleId IdType="pmc">PMC5654930</ArticleId>
            <ArticleId IdType="pubmed">29066545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bojer M.S., Lindemose S., Vestergaard M., Ingmer H. Quorum Sensing-Regulated Phenol-Soluble Modulins Limit Persister Cell Populations in Staphylococcus aureus. Front. Microbiol. 2018;9:255. doi: 10.3389/fmicb.2018.00255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2018.00255</ArticleId>
            <ArticleId IdType="pmc">PMC5826201</ArticleId>
            <ArticleId IdType="pubmed">29515541</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
